Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low-frequency HIV-1 drug resistance mutations in antiretroviral naïve individuals in Botswana.

Medicine - 15 Jul 2022

Maruapula Dorcas, Seatla Kaelo K, Morerinyane Olorato, Molebatsi Kesaobaka, Giandhari Jennifer, de Oliveira Tulio, Musonda Rosemary M, Leteane Melvin, Mpoloka Sununguko W, Rowley Christopher F, Moyo Sikhulile, Gaseitsiwe Simani

Abstract excerpt

BACKGROUND: Individuals living with human immunodeficiency virus (HIV) who experience virological failure (VF) after combination antiretroviral therapy (cART) initiation may have had low-frequency drug resistance mutations (DRMs) at cART initiation. There are no data on low-frequency DRMs among cART-naïve HIV-positive individuals in Botswana. METHODS: We evaluated the prevalence of low-frequency DRMs among...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Anti-Retroviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Botswana

Share to Drug Resistance, Viral

Share to Genotype

Share to HIV Infections

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 35838991
DOI: 10.1097/MD.0000000000029577
PMCID: PMC11132386

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low-frequency HIV-1 drug resistance mutations in antiretroviral naïve individuals in Botswana.PMID 35838991Read ↗

HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.Semantic proximity Read ↗

High prevalence of reverse transcriptase inhibitors associated resistance mutations among people living with HIV on dolutegravir-based antiretroviral therapy in Francistown, Botswana.Semantic proximity Read ↗

Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen.Semantic proximity Read ↗

Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana.Semantic proximity Read ↗

Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals.Semantic proximity Read ↗

High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in Botswana.Semantic proximity Read ↗

Prevalence and Evolution of Low Frequency HIV Drug Resistance Mutations Detected by Ultra Deep Sequencing in Patients Experiencing First Line Antiretroviral Therapy FailureSemantic proximity Read ↗

Patterns of pretreatment drug resistance mutations of very early diagnosed and treated infants in Botswana.Semantic proximity Read ↗

HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana.Semantic proximity Read ↗

Fostemsavir resistance-associated polymorphisms in HIV-1 subtype C in a large cohort of treatment-naïve and treatment-experienced individuals in Botswana.Semantic proximity Read ↗

High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine Among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in BotswanaSemantic proximity Read ↗

Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutations on Antiretroviral Therapy Outcomes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.